Neonatal Cardio-Pulmonary Outcome Measure
N-COM
Scale Development ,Content Validation and Reliability Testing of Neonatal Cardio-pulmonary Outcome Measure (N-COM) in Neonates Admitted in Neonatal Intensive Care Unit
2 other identifiers
observational
30
1 country
1
Brief Summary
Neonatal Cardio-Pulmonary outcome measure (N-COM) will be used to assess the overall status of pulmonary and cardiac vascular system of neonates in Neonatal Intensive Care Unit (NICU). There are many scales available which are helpful for assessing behavior, pain, and neurological status of neonates but there is no scale available till now which can help to assess cardio-pulmonary status of neonates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2020
CompletedFirst Posted
Study publicly available on registry
March 27, 2020
CompletedStudy Start
First participant enrolled
August 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedApril 8, 2021
April 1, 2021
7 months
March 6, 2020
April 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Neonatal Cardio-pulmonary outcome measure (N-COM)
Changes in pre and post Neonatal-cardio-pulmonary outcome measure (N-COM) will be noted. In pulmonary system, cyanosis (peripheral and central cyanosis), nasal grunting, chest retractions, respiratory rate, SPO2, nasal flaring, chest symmetry etc will be checked. In the cardiovascular system, heart rate, pulse rate, congenital heart defects, chest symmetry, heart sounds etc will be checked.
Baseline, PRE INTERVENTION, 1 year POST INTERVENTION
Interventions
Neonatal cardio-pulmonary outcome measure will be used to assess overall status of pulmonaryand cardio-vascular system
Eligibility Criteria
Neonates who are suffering from cardio-pulmonary conditions will be taken in the study such as- Respiratory distress syndrome, Pneumonia, Congenital heart defects etc.
You may qualify if:
- Preterm and full term neonates with cardio-pulmonary conditions Stable Neonates
You may not qualify if:
- Neonates with severe disability Parents who are not wiling to participate their newborn in study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Asir John Samuellead
Study Sites (1)
Maharishi Markandeshwar (M.M) Hospital, Mullana, Ambala, Haryana
Mullana, Haryana, 133207, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Asir J Samuel, MPT, PhD
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
- PRINCIPAL INVESTIGATOR
Pooja Mehra, BPT, (MPT)
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
- STUDY DIRECTOR
Neha Sharma, MPT
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 6, 2020
First Posted
March 27, 2020
Study Start
August 31, 2020
Primary Completion
March 25, 2021
Study Completion
March 31, 2021
Last Updated
April 8, 2021
Record last verified: 2021-04